Here you will find Information Letters and so-called "Rote-Hand-Briefe" sent out by pharmaceutical companies informing healthcare experts about newly identified major drug-associated risks and measures to reduce them. The files are available in German only.
The information published here only applies to drugs which are in the BfArM's responsibility.
For "Rote-Hand-Briefe" and Information Letters published by the Paul-Ehrlich-Institute for vaccines and biomedical products please click here.
Active substance fluorescein-sodium
Active substance fluorescein sodium
Active substance etravirin
Active substance nilotinib